BC3H1 is a cell line that undergoes a musclelike pattern of differentiation under the appropriate conditions. We have examined the control of the synthesis of proteins characteristic of differentiated muscle in these cells as a function of their position in the cell cycle. We define two positions in the cell cycle where BC3H1 cells can remain stably quiescent. Gid is a restriction point early in the GI portion of the cell cycle that permits the synthesis of muscle-specific proteins and is probably identical to Go. The second restriction point, Glq, occurs approximately 4 hr later in the GI portion of the cell cycle and does not pennit the synthesis of musclespecific proteins. Movement of the cells from Gld to Glq occurs when fibroblast growth factor is added to the cells and is reversed when this growth factor is removed. Repression of the synthesis of muscle-specific proteins occurs when fibroblast growth factor is added to cells in Gid. In the case of the muscle form of creatine phosphokinase (M-CPK), the decline in the rate synthesis of this protein is a consequence of a decreased level of its mRNA. By contrast, the repression of a-actin synthesis, a protein synthesized only in differentiated cells, appears to be controlled at the translational level. The effect of fibroblast growth factor and other mitogens in these cells require activation of tyrosine kinase(s), but the intracellular targets of these kinases are not known. Studies by others suggest that activation of the ras oncogene can mimic the action of mitogenic polypeptides on these and other muscle cells. However, these observations do not prove that activation of the ras protooncogene is directly responsible for the effect of mitogenic polypeptides on these cells.
Introduction
The control of cell differentiation is one of the central problems of modern biology. Studies of muscle differentiation have been at the forefront of this field because of the availability of defined (often cloned) cells that can be induced to differentiate under controlled conditions in the laboratory.
It is frequently true that the study of slightly abnormal cells, in which the pathway of differentiation has been partially altered, provides unique insights into the normal sequence of events. The BC3H1 cell line (1) is a nonfusing muscle cell line that has been particularly useful in this regard. These cells do not fuse, but under appropriate conditions, differentiate. Differentiation is defined here as a large increase in the rate of synthesis of proteins characteristic of mature muscle such as M-CPK (1-4), vascular smooth muscle a-actin (a-actin) (5, 6) , and the nicotinic acetylcholine receptor (AChR) (1, 7, 8) (Fig. 1) . The advan-tage of the BC3H1 cell line is that the differentiation process can be reversed by the addition of serum or well-characterized mitogenic polypeptides such as fibroblast growth factor (FGF) (4, 6, (9) (10) (11) (Fig. 1) . We summarize here our current knowledge derived from work in a number of laboratories in addition to our own of this process and speculate on the broader implications of this work for our understanding of muscle differentiation.
Differentiation of BC3H1 Cells
Figure 2 provides a graphic description of our current knowledge of differentiation in BC3H1 cells. The experimental observations on which this is based are found in the original publications (4, 6, 9) and will only be mentioned briefly. In Figure 2 we show the cell cycle of eukaryotic cells, and we identify two restriction points at which cells can remain quiescent and viable, both in the G1 portion of the cell cycle. Gld is equivalent to Go (12) and represents a restriction point permissive for cell differentiation, while Glq, 4 to 6 hr further in the GI phase of the cell cycle, is nonpermissive for cell differentiation (6, 9) .
When exponentially growing BC3H1 cells that are at a cell density high enough to allow extensive cell-cell contact are transferred from a medium containing high concentrations of serum to a medium containing low levels 20 (4, 9) . Briefly, cells were labeled for 1.5 hr with "S-methionine and CPK was immunoprecipitated from cell homogenates. The muscle and brain isozymes were separated by SDS-gel electrophoresis. After fluorography of the gels, the amount of "S-CPK was quantitated by densitometry and normalized to the rate of total protein synthesis. The rate of isoactin synthesis (C-E) was determined as described (6) . Briefly, cells were labeled for 1 hr with 35S-methionine and the actins were purified from cell homogenates using DNase I affinity chromatography. The 35S-actins were then subjected to isoelectric focusing to separate the a-, fi-, and y-isoforms or to SDS-gel electrophoresis to determine the amount of total "5S-actin. The amount of "5S-actin in the gels was quantitated as for M-CPK.
of serum, they arrest in Gld and initiate a differentiation
program that results in the accumulation of high levels of M-CPK (1-4), AChR (1, 7, 9, 13) , and a-actin (6), while the rate of synthesis of nonmuscle (3- and y-actin is decreased (6) (Fig. 1 synthesis of mRNAs absent in logarithmically growing cells (5, 14) ; hence, induction of differentiation involves transcriptional control of these genes. The difference in the level of these proteins between growing and differentiating cells can be several hundredfold (Fig. 1) . When high concentrations of serum are added to differentiated BC3H1 cells, the cells reinitiate growth (3) (4) (5) (6) (7) (8) (9) (10) (11) . Concomitantly, the synthesis of muscle-specific proteins ceases (3) (4) (5) (6) (7) (8) (9) (10) (11) , and the cells initiate the synthesis of proteins characteristic of growing cells, for example P and y actin (5, 6) (Fig. 1 ). Serum is a complex mixture of molecules, and it is impossible to ascertain whether the effects of serum on the differentiated phenotype are due to a single effector molecule or whether multiple components are involved. As will be shown, the multiple components are probably involved.
Since the inhibition of the differentiation program occurs when cell growth resumes, it is tempting to examine known mitogenic polypeptides for their ability to influence growth and differentiation in BC3H1 cells. Lathrop et al. could show that either highly purified acidic FGF (aFGF) or relatively crude basic FGF (bFGF) when added to differentiated BC3H1 cells blocked expression of M-CPK (4). However, the addition of these polypeptides to cells initially in Gld was not sufficient to initiate cell growth (6, 9) . The P-transforming growth factor (P-TGF) affects differentiation of BC3H1 cells similarly to FGF (13) . More recent observations suggest that in some subpopulations or clone(s) of BC3H1 cells, epidernal growth factor (EGF) has a similar effect on the differentiation program as FGF but EGF allows differentiated BC3H1 cells to reinitiate growth (15) .
A variety of observations indicate that addition of FGF to BC3H1 cells in Gld results in movement of these cells from Gld to a new restriction point Glq about 4 hr closer to the G1-S boundary than Gld. These observations can be summarized as follows: a) when stimulated to divide by addition of serum, cells in Glq enter the S phase of the cell cycle 4 to 6 hr before cells in Gld (6, 9) ; b) addition of FGF to cells in Gld results in a rapid and transient induction of the synthesis of the c-fos protooncogene characteristic of cells progressing from Gld (Go) to G1 (6); c) addition of FGF to cells in Gld results in significant induction of the synthesis of ornithine decarboxylase (9) , which is characteristic of cells transiting through early parts of G1 (16); and d) the transit of cells from Gld to Glq requires 4 to 6 hr of exposure to FGF (9), although it seems likely that as soon as cells exit Gld they are no longer permissive for the synthesis of differentiated proteins.
The levels of control of the synthesis of various proteins associated with the differentiated phenotype appears to be different (Table 1 ). When cells exit from Gld, synthesis of M-CPK mRNA ceases (6, 10) (Fig. 3) , the message decays with a half-time of about 8 hr (independent of whether cells are in Gld or not, (10) , and there is a corresponding decline in the rate of M-CPK synthesis (9) . The rate of a-actin synthesis also declines when cells exit
Gld (5, 6) ; however, this rate of synthesis is not a reflection of levels of a-actin mRNA, which remain relatively high (6) (Fig. 3 , Table 1 ). This is true whether the exit from Gld is induced by addition of FGF, which brings cells to Glq (6) , or by addition of EGF or serum, which, in appropriate EGF responsive clones, allows cells to continue through the cell cycle (15 (5, 6) , and the addition of FGF to such cells does not increase the rate of P and y actin synthesis (6) . In fact, the rate of p and y actin synthesis in FGF-treated cells continues to decrease at the same rate as in differentiating cells which remain in GId (6) (Fig. 1) . Addition of serum to cells in Gld does result, as expected, in a rapid increase in the rate of synthesis of P and y actins. However, as discussed in Wice et al. (6) , factors in serum affect the rate of synthesis of these proteins independent of position in the cell cycle.
Removal of FGF from the media of cells arrested in Glq allows the cells to return to Gld without going through the full cell cycle (9) . Thus, transit from Gld to Glq is fully reversible, and, at least for these cells, induction of the differentiation program does not require a terminal cycle of DNA synthesis (22) .
Intracellular Signals that Control Differentiation of BC3H1 Cells
The receptor for a number of mitogenic polypeptides are tyrosine-specific protein kinases, and the FGF receptor appears to fall into this category as well (23) . Ib assess whether the phosphorylation of proteins on tyrosine residues was important for the control of cell differentiation, we examined the effects of vanadate, an inhibitor of tyrosine-specific protein phosphatases (24) (25) (26) (27) Experiments in which the rate of a-actin synthesis was measured after addition of FGF to cells could be interpreted to indicate that repression occurs without significant lag (2 hr) (6), but the complexity of the system requires that this interpretation be made with caution. Maximum repression of actin synthesis requires up to 12 hr of exposure to FGF and occurs in the absence of a large decrease in a-actin mRNA levels (6) . Typical results are presented in Table 1 . If these data are taken at face value, the intracellular signal responsible for repression of a-actin synthesis is generated rapidly after addition of FGF and before the cells reach Glq.
The decrease in the rate of synthesis of M-CPK following addition of FGF to BC3H1 cells also occurs without a significant lag (9) . Measurements of the level of M-CPK mRNA in BC3H1 cells following addition of FGF again indicates very little, if any, lag in the decay of the level of this mRNA, which is dependent on new protein synthesis (10). These results suggest that the mitogenic polypeptide, FGF, induces the synthesis of one or more proteins that repress the muscle-specific differentiation program of BC3H1 cells.
FGF treatment of quiescent 3T3 fibroblasts results in their reentering and progressing through the cell cycle. Concomitantly, these cells transiently express several protooncogenes such as c-fos and c-myc in a sequential fashion (28, 29) , suggesting that these gene products are important for movement from Go into G1. It is therefore interesting to speculate that these gene products are involved in the inhibition of the muscle-specific phenotype since quiescent, differentiated BC3H1 cells express these proteins in a similar fashion following their treatment with FGF or serum (6) . Two laboratories (30, 31) have examined the effect of increasing levels of c-myc expression on myogenic differentiation. In one case (31), transfection of BC3H1 cells with the c-myc gene was only able to partially inhibit the expression of the muscle specific phenotype. In the second case (30), L6E9-B cells, which were biochemically differentiated but nonfused (fusion was blocked by chelating Ca2 + with EGTA), responded to serum treatment by transiently expressing c-myc mRNA and reentering the cell cycle. However, the levels of muscle-specific mRNAs were not greatly affected by this treatment, even 96 hr after serum addition. These results suggest that c-myc expression can, at best, only partially block the differentiation of muscle cells. Conversely, the oncogenic forms of N-ras and H-ras have been shown to completely block myoblast differentiation (32) . Transfection of the C-2 myoblast cell line with the N-ras oncogene under the control of a steroid-inducible promoter only blocked cellular differentiation when the cells are incubated with dexamethasone (33) .
Can we conclude from these experiments that the expression of c-ras following addition of mitogen controls muscle differentiation? The answer is no. Induction of c-ras by mitogens (when observed) is a relatively late event after mitogen addition to cells (> 8 hr) (34) . However, repression of the expression of muscle-specific proteins is initiated within 1 and maximally 2 hr after addition of mitogen to cells. Moreover, transfection of myoblasts with c-ras did not repress the muscle phenotype (32) . Additionally, c-ras expression usually changes very little, if at all, as a function of position in the cell cycle (28) .
In order to show that c-ras directly participates in the repression of muscle-specific differentiation, it would be necessary to demonstrate that the inhibition of c-ras expression blocks mitogen-induced repression of the musclespecific phenotype. This could be accomplished by microinjecting antibodies directed against c-ras into differentiated BC3H1 cells. Such experiments have been successfully used to inhibit the NGF-induced differentiation of PC12 cells (35) and the serum-induced growth of quiescent 3T3 cells (36) . Alternatively, antisense oligonucleoside methylphosphonates (oligo MP) (37) (4, 6, 9, 10, 13) . It is not clear, however, whether these four points of regulation can be controlled independently by mitogens or whether control is coordinate under all circumstances.
Myoblasts, unlike BC3H1 cells, fuse and irreversibly withdraw from the cell cycle and simultaneously become refractory to the repression by mitogens, but we do not understand the molecular basis of this phenomenon. Several laboratories have suggested that mitogens cease to be effectors because the cells lose mitogen receptors. This is an attractive idea but one for which the evidence is conflicting. For example, in L6E9 cells induction of c-myc by mitogens can occur in differentiated cells, suggesting the presence of mitogenic receptors (30) . Similarly, the ability of P-transforming growth factor (j3-TGF) to block myoblast differentiation is not due to the disappearance of P-TGF receptors from these cells (41) . By contrast, experiments with C-2 muscle cells suggest that fusion but not withdrawal from the cell cycle and differentiation results in downregulation of P-TGF and EGF receptors (41 Work from the authors' laboratories is supported by grants from the National Institutes of Health, GM38285. We are grateful to a number of collaborators who have participated in the work summarized here as acknowledged in appropriate references, in particular E. Olson and B. Lathrop. We acknowledge with thanks the careful reading of this manuscript and the valuable suggestions by J. Gordon.
